e-School Series 6
Directing the immune response to specific tumor antigens using modified oncolytic viruses Vincenzo Cerullo, University of Helsinki
Oncolytic virotherapy
Stephen Russell, Mayo Clinic, Rochester
Updates with engineered T cells
Carl June, Upenn, Philadelphia
VIDEO AVAILABLE FOR ESGCT MEMBERS ONLY
Cancer immunotherapy: beyond CAR T cells
Chiara Bonini, IRCCS Ospedale San Raffaele